Lumea Announces Collaboration with Cleveland Diagnostics to Enable Greater Access to IsoPSA® Testing for Prostate Cancer Risk Stratification LEHI, UT, UNITED STATES, December 17, 2025 /EINPresswire.com/ — Lumea, the U.S….
ZayaAI is embedding Lumea’s viewer into the Zaya LIS, creating a single digital workspace for pathologists. This streamlines workflows and boosts efficiency. LEHI, UT, UNITED STATES, December 9, 2025 /EINPresswire.com/…
Lumea and Valar Labs today announced a partnership to integrate Valar Labs’ Vesta tests into the Lumea digital pathology platform. LEHI, UT, UNITED STATES, October 9, 2025 /EINPresswire.com/ — Lumea,…
LEHI, UT –October 6, 2025– Lumea, a leader in digital pathology solutions, has been named the Healthcare Tech Innovator of the Year 2025 – Western USA and the Leading Provider…
Lumea is recognized on the Utah Business Fast 50 list for its digital pathology tech, reinforcing its role as a leader in Utah’s innovative business landscape. LEHI, UT, UNITED STATES,…
Lumea, a leader in digital pathology, was named to the Inc. 5000 list, earning a spot in the top half of America’s fastest-growing private companies. LEHI, UT, UNITED STATES, August…
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.
